Olea Venture Partners invests in EBO to accelerate proven AI adoption in healthcare

Healthcare and life sciences investor backs EBO’s expansion across healthcare systems, supporting wider adoption of its AI-powered patient engagement and workflow automation platform across Europe and into the United States.

From left: Dr. Gege Gatt, CEO of EBO; Dr. Harietta Eleftherochorinou, Founding and Managing Partner at Olea Venture Partners; and Dr. Lampros Kourtis, Managing Partner at Olea Venture Partners.

From left: Dr. Gege Gatt, CEO of EBO; Dr. Harietta Eleftherochorinou, Founding and Managing Partner at Olea Venture Partners; and Dr. Lampros Kourtis, Managing Partner at Olea Venture Partners.

Olea Venture Partners, a healthcare and life sciences investor, has completed an investment in EBO, a provider of AI-powered patient engagement solutions, to support the next phase of the company’s growth.

The investment will accelerate adoption of EBO’s technology across health systems and healthcare providers, support expansion into new clinical and operational workflows, and fund further international expansion across Europe and into the United States.

“In a field still defined by promise, EBO is defined by proof. The company is already delivering measurable impact in some of the most complex healthcare environments, with patient adoption rates of up to 97%, significant operational capacity released for hospital teams and customer ROI of up to 5x.”
Harietta Eleftherochorinou
Dr. Harietta Eleftherochorinou
Founding and Managing Partner at Olea Venture Partners

Built for real-world impact

24

Live deployments

across UK NHS Trusts and hospitals

97%

Patient adoption

patient adoption rates of up to 97%

5x

Customer ROI

operational capacity released for hospital teams and customer ROI of up to 5x

Backed by the European Investment Fund and supported by EquiFund II, Olea combines growth capital with hands-on strategic and operational support, drawing on experience across AI, healthcare, science and commercialisation.

EBO’s AI technology automates complex patient interactions, including appointment management, self-assessments and pathway communications, delivering improved patient experiences and sustained operating savings.

The platform operates as infrastructure inside regulated healthcare workflows, not as a standalone AI tool.

"What stands out about EBO is that it solves a clear operational need with a platform built for healthcare and proven adoption across markets. The next phase is about scaling what already works. Olea will support the EBO team as it deepens adoption across the UK, strengthens its Southeast European presence, and enters the United States with a particular focus on health-system partnerships, commercial strategy and building a repeatable model for international expansion.”
Dr. Lampros Kourtis
Dr. Lampros Kourtis
Managing Partner at Olea Venture Partners

The company has established commercial operations in the UK, Italy, Greece and Malta, with 24 live deployments across UK NHS Trusts and hospitals.

Dr. Harietta Eleftherochorinou said:
 
“Gege and the EBO team have shown that they can do what remains difficult in healthcare AI: move from promising technology to trusted, repeatable deployment in real health systems. They can navigate complex integrations, meet the governance and safety standards of healthcare systems, and get the technology adopted in day-to-day clinical and operational workflows.”

Making access to care simpler, more inclusive and more human

Dr. Gege Gatt, CEO and Founder of EBO, said, “This investment is a vote of confidence in EBO and in the scale of the opportunity ahead. With Olea, we have a partner who understands that healthcare innovation succeeds through trust, evidence and disciplined execution.”

“Together, we will help more healthcare organisations make patient access simpler, release capacity for their teams and adopt AI responsibly within the systems and safeguards they already rely on.”

The investment marks the next stage in EBO’s growth as the company scales a healthcare AI platform already deployed across multiple markets and clinical environments.

To learn more about our AI-powered solutions, access EBO’s AI for healthcare guide here.

News & Updates from EBO

Find out more about our experiences and consumer-generated insights. Here we share EBO's news, so that you can stay up-to-date with what we have to offer.

Enlivio partners with EBO

EBO achieves EMIS Web Assured Integration through Enlivio Health Partnership

EBO has achieved Enlivio Health Assured Partner status, enabling secure integration between its Intelligent Patient Portal and Enlivio Health’s EPR software; EMIS Community and EMIS
Harrow Health Expands Digital Access and Patient Self-Service with EBO’s AI Solutions

Harrow Health Expands Digital Access and Patient Self-Service with EBO’s AI Solutions

Harrow Health is expanding digital access to healthcare through EBO’s AI-powered SPAN and Intelligent Patient Portal. The solutions will help patients find the right services,
EBO has been named as a supplier on Government Commercial Agency’s G-Cloud 15 Framework

EBO named as a supplier on G-Cloud 15 Framework

EBO has been named as a supplier to the UK Government’s G-Cloud 15 framework, providing public sector organisations with an established route to access EBO’s

Virtual Agents help businesses drive conversations.

Here are a few words from our clients on their experience with our solution.

Back to top